Thyroid cancer, papillary

Common Name(s)

Thyroid cancer, papillary

Papillary thyroid cancer is the most common type of thyroid cancer, making up about 80% of all thyroid cancer cases. Papillary carcinoma usually arises as an irregular, solid mass that comes from thyroid tissue. If the tumor is small and not invading other tissues then treatment could consist of removal of the lobe of the thyroid that contains the tumor. Because the thyroid is the only part of the body that can absorb iodine, treatment for tumors that are very large or ones that have spread could also consist of giving the patient radioactive iodine. Papillary thyroid cancer occurs most frequently in women 20-55 years old.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thyroid cancer, papillary" for support, advocacy or research.

ThyCa: Thyroid Cancer Survivors' Association, Inc.

* To Educate, so we and our families better understand our disease. * To Participate, so others learn from our experience. * To Communicate, so we and our health care professionals better understand each others' needs. * To Support Research, for a future free of thyroid cancer.

Last Updated: 20 Feb 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thyroid cancer, papillary" for support, advocacy or research.

ThyCa: Thyroid Cancer Survivors' Association, Inc.

* To Educate, so we and our families better understand our disease. * To Participate, so others learn from our experience. * To Communicate, so we and our health care professionals better understand each others' needs. * To Support Research, for a future free of thyroid cancer.

http://www.thyca.org

Last Updated: 20 Feb 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Thyroid cancer, papillary" returned 0 free, full-text research articles on human participants.

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Thyroid cancer, papillary" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
 

Status: Recruiting

Condition Summary: Recurrent Thyroid Cancer; Stage I Follicular Thyroid Cancer; Stage I Papillary Thyroid Cancer; Stage II Follicular Thyroid Cancer; Stage II Papillary Thyroid Cancer; Stage III Follicular Thyroid Cancer; Stage III Papillary Thyroid Cancer; Stage IVA Follicular Thyroid Cancer; Stage IVA Papillary Thyroid Cancer; Stage IVB Follicular Thyroid Cancer; Stage IVB Papillary Thyroid Cancer; Stage IVC Follicular Thyroid Cancer; Stage IVC Papillary Thyroid Cancer

 

Last Updated: 28 Jul 2014

Go to URL
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
 

Status: Recruiting

Condition Summary: Insular Thyroid Cancer; Recurrent Thyroid Cancer; Stage I Follicular Thyroid Cancer; Stage I Papillary Thyroid Cancer; Stage II Follicular Thyroid Cancer; Stage II Papillary Thyroid Cancer; Stage III Follicular Thyroid Cancer; Stage III Papillary Thyroid Cancer; Stage IVA Follicular Thyroid Cancer; Stage IVA Papillary Thyroid Cancer; Stage IVB Follicular Thyroid Cancer; Stage IVB Papillary Thyroid Cancer; Stage IVC Follicular Thyroid Cancer; Stage IVC Papillary Thyroid Cancer

 

Last Updated: 26 Aug 2014

Go to URL
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
 

Status: Recruiting

Condition Summary: Recurrent Thyroid Cancer; Stage IVA Follicular Thyroid Cancer; Stage IVA Papillary Thyroid Cancer; Stage IVB Follicular Thyroid Cancer; Stage IVB Papillary Thyroid Cancer; Stage IVC Follicular Thyroid Cancer; Stage IVC Papillary Thyroid Cancer

 

Last Updated: 26 Aug 2014

Go to URL